FDA Investigator Barbara A Rusin

Barbara A Rusin has conducted inspections on 114 sites in 5 countries as of 09 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
114
Last Inspection Date:
09 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100005401
Countries of Inspections:
United States of America, India, Canada, Germany, Russian Federation
FDA Investigators that have inspected at least one site in common with Barbara A Rusin:
Adam J Taylor, Alanna L Mussawwir Bias, Allen F Hall, Amanda E Lewin, PhD, Amy S Graf, Andrace L Deyampert, Andrea A Branche, Andrea D Swingle, Angela J Alexander, Anthony R Petriella, Art O Czabaniuk, Ashley E Lewis, Azza Talaat, Barbara M Frazier, Bei Y He, Benjamin J Smith, Bleta Vuniqi, Brandon L Mariner, Brian P Putz, Brian R Yaun, Brittany M Lowe, Bryan J Love, Byron Ho, DVM, Carol Rivera Lopez, PhD, Catherine V Quinlan, CDR Kimberly Y Martin, Charles A Snipes, PhD, Charles M Spyr, Chelsea W Lamm, Corey K Reno, Corrine M Carter, Courtney N Long, Craig A Garmendia, Crystal M Young Lewis, David P Moorhead, Dawn C Olenjack, Dennis L Doupnik, Dina A Tallman, Douglas W Gronski, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Eileen J Bannerman, Emily B Camire, Emily J Orban, Eric S Pittman, Erma Zaimova, Gabryelle J Solverud, Gajendiran Mahadevan, PhD, Gale L Glinecki, Gary Durbiel Goldner, Geoffrey K Kilili, George C Amedro, Gerald Mierle, Gulshan R Anand, Hasan A Irier, PhD, Helen B Ricalde, Hoimay Chan, Hokenson, Hyojong Kwon, PhD, James R Fleckenstein, James W Leonette, Janete F Guardia, Jeffrey D Meng, Jennifer A Kemp, Jennifer C Adams, Jennifer C Johnson, Jennifer L Sheehan, John A Kadavil, PhD, Jose Ohernandez Guzman, Joseph R Haynes, Judith A Jankowski, Karen M Cooper, Katharine M Oaks, Kathryn G Brown, Kelley L Clark, Kip J Hanks, Kirtida Patel, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laura E Garcia, Laureen F Kononen, Lawrence Y Lee, PhD, LCDR Anastasia M Piliafas Brown, Lee Terry Moore, Leena Thomas, Leigh Anne Myers, Leslie A Paul, Lewis K Antwi, Li Hongpaul Yeh, PhD, Liming Zhang, Linda R Kuchenthal, Linda S Jozefiak, Lisa J Joseph, Lisa M Thursam, Lisa P Oakes, Lori A Gioia, LT Danielle S Mills, LT Skip A Payne, Luis A Dasta, Makini Cobourne Duval, PhD, Marcus L Head, Margaret N Persich, Marlon K Turner, Martin K Yau, PhD, Mary E Baker Brown, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michele L Forster, PhD, Michelle L Jones, Mikhail V Ovanesov, PhD, Myra K Casey, Nancy A Bellamy, Natalie A Mickelsen, DVM, Neali H Lucas, Nicola M Fenty Stewart, Niraj R Mehta, PhD, Patsy J Domingo, Patty P Kaewussdangkul, Paula J Bretz, Paula M Laplant, Rasha Bamieh, Rebecca E Dombrowski, Rebecca T Davis, Reginald Walker, Rosia E Nesbitt, Ruben C Ayala, PharmD, Ryan J Benedict, Saikat I Bhuiyan, Saleem A Akhtar, Samantha J Pinizzotto, D V M, Scott B Laufenberg, Seongeun Cho (Julia), PhD, Sheri L Stephenson, Sherri J Blessman, Sherri J Jackson, Sonya M Lambkin, Sripal R Mada, PhD, Susan D Yuscius, Susan M North, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracy R Ball, Travis R Hunt, Travis S Bradley, Twana R Chandler, Tyra L Vanleer, Uruaku A Obasi, Vesa Vuniqi, William D Bassett, Jr, William D Tingley, William R Brubaker, Wr Bowman, Xikui Chen (nmi), PhD, Zoey A Trombley

Barbara A Rusin's Documents

Publish Date Document Type Title
December, 2011 FDA 483 Clarita S. Ketels, D.O. - Form 483, 2011-12-02
July, 2008 FDA 483 The American National Red Cross - Form 483, 2008-07-02
January, 2009 EIR McLaughlin, Vallerie, MD - EIR, 2009-01-07
September, 2010 FDA 483 The American National Red Cross - Form 483, 2010-12-15
March, 2011 FDA 483 The American National Red Cross - Form 483, 2011-03-29
January, 2012 FDA 483 Jack Barkin, MD - Form 483, 2012-02-02
February, 2013 EIR Cayman Chemical Company, Inc. - EIR, 2013-02-28
November, 2013 EIR Charles River Laboratories - EIR, 2013-11-15
February, 2013 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2013-02-28
February, 2010 FDA 483 Martinez, Fernando - Form 483, 2010-02-10
May, 2014 EIR Charles River Laboratories - EIR, 2014-05-02
December, 2009 FDA 483 Miguelangelo J. Perez-Cruet, M.D., M.S. - Form 483, 2009-12-22
December, 2009 FDA 483 Response Miguelangelo J. Perez-Cruet, M.D., M.S. - Form 483R, 2009-12-06
June, 2010 FDA 483 American National Red Cross National Testing Lab - Form 483, 2010-06-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more